IP Library Granted Patent US 11,110,256
Granted Patent B2
US 11,110,256 · App. 16/039,661 · Granted Sep 7, 2021

Kit for treatment of sinusitis

Inventors: Christopher Lee Oliver (Denver, CO); Donald F. Schomer (Bellaire, TX); Harry Ross (Boulder, CO); William W. Cimino (Louisville, CO); Brian James Willoughby (Denver, CO)
Assignee: SINOPSYS SURGICAL, INC.
A61M27/002A61F9/00772A61M31/00A61M2210/0612A61M2210/0681
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,110,256
App. No.
16/039,661
Granted
Sep 7, 2021
Kind
B2
Abstract

An implant device is configured to be implanted in a fistula to fluidly connect the lacrimal apparatus and a paranasal sinus. A surgical tool has an implant the implant device mounted on a carrier. Various methods involve a fistula between the lacrimal apparatus and a paranasal sinus. A kit includes an entry device for use to form a fistula and an implant tool for use to implant an implant device following formation of a fistula.

Claims (33)

1. A kit for treatment of sinusitis through an implant device for implantation in a human to provide a fluid connection between a location in a lacrimal apparatus to a paranasal sinus through a fistula formed between the lacrimal apparatus and the paranasal sinus to provide direct medical access through the implant device from the lacrimal apparatus to the paranasal sinus, the kit comprising:

a first surgical tool having a first working member configured to form an initial fistula;

an implant device for implantation to fluidly connect a lacrimal apparatus to a paranasal sinus, the implant device comprising:

a proximal end at a first longitudinal end of the implant device;

a distal end at a second longitudinal end of the implant device that is longitudinally opposite the first longitudinal end;

a conduit extending from adjacent the proximal end to adjacent the distal end;

a first internal passage extending between the proximal end and the distal end and through the conduit, the first internal passage having a first end open at the proximal end and a second end open at the distal end; and

a length of the implant device longitudinally along the implant device between the proximal end and the distal end in a range of from 8 millimeters to 50 millimeters; and

wherein the conduit is constructed of polymeric material having a durometer (Shore A) in a range of from 50 to 100, and the implant device is configured to be implanted to fluidly connect the lacrimal apparatus to the paranasal sinus through the first internal passage of the implant device with the proximal end of the implant device disposed in the lacrimal apparatus with the first end of the first internal passage open to the lacrimal apparatus, the distal end disposed in the paranasal sinus with the second end of the first internal passage open to the paranasal sinus and the conduit disposed through an implantation fistula between the lacrimal apparatus and the paranasal sinus;

a carrier for carrying and positioning the implant device for implantation during an implantation procedure, the carrier comprising:

a second working member with a distal tip, the second working member being adapted to be disposed through the implantation fistula with the distal tip located in the paranasal sinus;

a hand-manipulable handle connected to the second working member; and

a second internal passage extending through the handle and the second working member to accommodate passage therethrough of a guide wire to guide the first surgical tool along the guide wire to the implantation fistula during an implantation procedure;

wherein:

the implant device is mountable on the carrier in a mounting position between the handle and the distal tip with the second working member disposed through the first internal passage and with the proximal end of the implant device disposed toward the handle and the distal end of the implant device disposed toward the distal tip of the second working member; and

the carrier is disengageable from the implant device for implant placement of the implant device disposed through the implantation fistula.

2. A kit according to claim 1 , comprising a guide wire that is passable through the second internal passage to guide the carrier to a location where the implant device is to be implanted.

3. A kit according to claim 1 , wherein the implant device comprises a head adjacent the conduit at the proximal end of the implant device; and wherein the head comprises a flanged tissue engagement surface on a side of the head disposed toward the conduit and configured to engage tissue outside of and adjacent to the implantation fistula when the implant device is implanted.

4. A kit according to claim 3 , wherein the head has a length dimension and a width dimension transverse to the length dimension with the length dimension being in a range of from 2 millimeters to 7 millimeters and the width dimension being in a range of from 2 millimeters to 5 millimeters.

5. A kit according to claim 4 , wherein the head has a circular outer edge and the length dimension and the width dimension are equal.

6. A kit according to claim 1 , wherein a length of the conduit is in a range of from 8 millimeters to 40 millimeters.

7. A kit according to claim 1 , wherein the implant device comprises a plurality of apertures through a wall of the conduit providing fluid communication from outside of the conduit to the first internal passage through the conduit, and wherein at least some of the apertures are located along the length at least 5 millimeters from the proximal end.

8. A kit according to claim 1 , wherein when the implant device is mounted in the mounting position the distal tip of the second working member is located at least 0.5 centimeter from the distal end of the implant device.

9. A kit according to claim 8 , wherein when the implant device is mounted in the mounting position the distal tip of the second working member is located not more than 4 centimeters from the distal end of the implant device.

10. A kit according to claim 9 , wherein when the implant device is mounted in the mounting position the distal tip of the second working member is located at least 0.75 centimeter from the proximal end of the implant device.

11. A kit according to claim 10 , wherein when the implant device is mounted in the mounting position the distal tip of the second working member is located not more than 7 centimeters from the proximal end of the implant device.

12. A kit according to claim 1 , wherein the distal tip of the second working member is blunt.

13. A kit according to claim 1 , comprising a treatment composition including a drug for treating the paranasal sinus.

14. A kit according to claim 13 , comprising a syringe containing the treatment composition.

15. A kit according to claim 13 , wherein the treatment composition includes at least one drug selected from the group consisting of anti-inflammatories, antimicrobials, analgesics, mucolytics, antivirals, decongestants, steroids, antihistamines, antibiotics and anti-fungals.

16. A kit according to claim 13 , wherein the treatment composition comprises an antibiotic and at least one drug selected from the group consisting of steroids and antihistamines.

17. A kit according to claim 1 , wherein the first working member comprises a cutting instrument selected from the group consisting of a needle, cutting cannula and trocar.

18. A kit according to claim 17 , wherein the first working member has a larger diameter than the second working member.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2019
From: OLIVER, CHRISTOPHER LEE; SCHOMER, DONALD F.; ROSS, HARRY; CIMINO, WILLIAM W.; WILLOUGHBY, BRIAN JAMES
To: DCS SURGICAL, INC.
Reel/Frame 048821/0863 →
CHANGE OF NAME Recorded Apr 8, 2019
From: DCS SURGICAL, INC.
To: SINOPSYS SURGICAL, INC.
Reel/Frame 048825/0929 →
Continuity (6)
Continuation 15077020 · Mar 22, 2016
Division 13877893
Continuation In Part 13225213 · Sep 2, 2011
Provisional Application 61528058 · Aug 26, 2011
Provisional Application 61404716 · Oct 8, 2010
Related Publication 20190015643A1 · Jan 17, 2019